Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.
about
Drug treatment of pulmonary hypertension in childrenPharmacotherapy for pulmonary hypertensionPulmonary Hypertension in Children.Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH).Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settingsProstacyclin in the intensive care setting.Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.Medical therapy for pediatric pulmonary arterial hypertensionNon-congenital heart disease associated pediatric pulmonary arterial hypertensionSevere paediatric pulmonary hypertension: new management strategiesResponse to bosentan in children with pulmonary hypertension.Advances in pediatric pulmonary arterial hypertension.Transition from intravenous epoprostenol to oral or subcutaneous therapy in pulmonary arterial hypertension: a retrospective case series and systematic reviewTreatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence.A New Era in Medical Management of Severe Pediatric Pulmonary Arterial Hypertension.Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan.Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Pulmonary Hypertension.Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension.Safety and tolerability of bosentan in the management of pulmonary arterial hypertension.Current challenges in pediatric pulmonary hypertension.Advances in therapies for pediatric pulmonary arterial hypertension.Pulmonary hypertension and breathlessness: is it a combination we can ignore?Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.
P2860
Q26996078-DCBCDD34-9988-491A-A1A4-E337F5AD87EFQ27022763-87C24600-868E-4FC6-B61C-134D20241BA9Q30248871-0E774019-11A9-435A-B992-A3A51D8A5B7AQ33788506-4A632418-10DB-40F0-94CF-2A76BE61263EQ34254924-51470BEA-9850-427F-9929-894DFA562B53Q35050464-65034ADB-1CD7-481D-B1B9-616B3393625FQ35076114-C3FFD235-C80B-4814-822C-B88899AA13DCQ35079604-B68AB855-7217-428C-8BDA-AA297F76DBEAQ35165691-96D89FEF-E4C0-453B-BCFD-AE6587BFDE3DQ35280612-F8649F3E-5DD4-4EE6-A1AE-BFD0E875136EQ35771679-845066D5-462D-48CA-886C-0C9C1688E981Q35869437-01B2F75B-D37F-4BF2-97DA-59A182981CFBQ35895629-C9B3E583-1F3A-47C8-A8EE-C47E51BA422AQ36192759-4D35646A-4366-4650-9763-41507B1D7CF2Q36481525-F7F35B43-D745-4900-820B-CB02C0280259Q36570843-D9E9F8EA-EFE7-48F9-863E-D0ABAE69B148Q36763080-227FFFFF-7F49-4C2C-A8F2-8F5367399A06Q37019838-6921009B-47D5-439A-86B4-B8B0E764419DQ37403190-1049D156-C81F-44FC-AA6B-7B132D677A4EQ37540613-FAB33B7C-6485-44BB-8661-274A02194E93Q37755020-6BC0AD1B-6D31-459A-AA56-D751026B1E3BQ38175197-B1869F2D-67C8-4563-B3B7-DA42D0034F26Q55001904-C8BCC47A-9473-4E89-9D8C-C19B03341949
P2860
Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Weaning and discontinuation of ...... eceiving concomitant bosentan.
@ast
Weaning and discontinuation of ...... eceiving concomitant bosentan.
@en
type
label
Weaning and discontinuation of ...... eceiving concomitant bosentan.
@ast
Weaning and discontinuation of ...... eceiving concomitant bosentan.
@en
prefLabel
Weaning and discontinuation of ...... eceiving concomitant bosentan.
@ast
Weaning and discontinuation of ...... eceiving concomitant bosentan.
@en
P2093
P2860
P1476
Weaning and discontinuation of ...... eceiving concomitant bosentan.
@en
P2093
Aimee Doran
Anji Yetman
D Dunbar Ivy
Deborah Bingaman
Lori Claussen
P2860
P304
P356
10.1016/J.AMJCARD.2003.12.031
P407
P577
2004-04-01T00:00:00Z